Literature DB >> 2019479

Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.

M J Jacobs1, P J Jörning, E J Van Rhede van der Kloot, P J Kitslaar, H A Lemmens, D W Slaaf, R S Reneman.   

Abstract

Microcirculatory and haemorheological parameters were investigated before and after plasmapheresis in eighteen patients with secondary Raynaud's phenomenon based on progressive systemic sclerosis. After 4 plasmaphereses, once a week, all patients claimed explicit improvement of their complaints. Raynaud's phenomenon and especially the reaction upon cold provocation had disappeared and skin ulcers healed. Red blood cell (RBC) velocity increased significantly (p less than 0.001) after 4 weeks plasmapheresis. RBC aggregation and plasma viscosity were significantly lower (p less than 0.001) after the last plasmapheresis than before treatment. After 3 years four patients were still free of complaints, but in 14 patients the symptoms of Raynaud's phenomenon had reappeared after 6 to 9 months. The skin ulcers, however, did not return in these patients. RBC aggregation and plasma viscosity returned to the initial values after 9 months, while skin capillary blood flow remained significantly enhanced for 24 months. The finding that restoration of RBC aggregation and plasma viscosity to normal level is associated with enhanced skin capillary blood flow, indicates that disturbed haemorheology plays a role in the diminished skin blood flow, as observed in patients with secondary Raynaud's phenomenon. In these patients, plasmapheresis can be considered to treat severe ischemia of the digits.

Entities:  

Mesh:

Year:  1991        PMID: 2019479

Source DB:  PubMed          Journal:  Int J Microcirc Clin Exp        ISSN: 0167-6865


  6 in total

1.  Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?

Authors:  Bihter Senturk; Bahri Akdeniz; Mehmet Birhan Yilmaz; Buse Ozcan Kahraman; Burak Acar; Sadettin Uslu; Merih Birlik
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

Review 2.  Current therapy of systemic sclerosis (scleroderma).

Authors:  U Müller-Ladner; K Benning; B Lang
Journal:  Clin Investig       Date:  1993-04

3.  [Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality].

Authors:  M O Becker; U Müller-Ladner; G Riemekasten
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

4.  Capillary microscopy in patients with vasospastic and arterial occlusive diseases.

Authors:  M J Jacobs; I D Gregoric; G J Reul
Journal:  Tex Heart Inst J       Date:  1992

5.  Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study.

Authors:  Peter Korsten; Timothy B Niewold; Michael Zeisberg; Tammy O Utset; Daniel Cho; Lawrence S Zachary; Nadera J Sweiss; Suncica Volkov
Journal:  Autoimmune Dis       Date:  2017-11-29

Review 6.  Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis.

Authors:  Edward S Harris; Herbert J Meiselman; Patrick M Moriarty; Allan Metzger; Miroslav Malkovsky
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.